Correlation between the rate of intravitreal injections, use of aflibercept as a second-line treatment and visual impairment for wet AMD in Finland.
Petteri KaresvuoLaura HakkalaKai KaarnirantaHannu UusitaloMatti OjamoRaimo TuuminenPublished in: Acta ophthalmologica (2020)
These results emphasize that the use of aflibercept injections as a second-line treatment may decrease new onset visual impairments.